Uterine arterial embolization in the management of symptomatic leiomyomata

Journal of Interventional Radiology

Volumn 13, Issue 1, 1998, Pages 16-19

  Ellis, P K ^a,b   Kidney, D D ^a,b   Deutsch, L S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLYVINYL ALCOHOL SPONGE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CASE REPORT; CATHETER; FEMALE; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; INTRAARTERIAL DRUG ADMINISTRATION; LEIOMYOMATOSIS; TREATMENT OUTCOME; UTERINE ARTERY; UTERUS MYOMA; VEIN THROMBOSIS;

EID: 0031835983     PISSN: 02680882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Farrer-Brown G, Beilby JOW, Tarbit MH. The vascular patterns of myomatous uteri. J Obstet Gynaecol Br Commonwealth 1970; 77: 967-975.
2. Ravina JH, Herbreteau O, Ciraru-Vigneron N et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671-672.
3. Goodwin SC. Preliminary experience with uterine artery embolization for uterine fibroids. Personal communication.
4. Waters EG. Surgical management of postpartum hemorrhage with particular reference to ligation of uterine arteries. Am J Obstet Gynecol 1952; 64: 1143-1148.
5. Greenwood LH, Glickman MG, Schwartz PE, Morse SS, Demy DF. Obstetric and non-malignant gynecological bleeding: treatment with angiographic embolization. Radiology 1987; 164: 155-159.
6. Basche S, Glaser FH, Hensel G, Spitzbart H, Kachel R, Schmeisser G. Percutaneous transvascular embolization as a palliative measure in bleeding gynaecological malignancies of the pelvis. Zentralblatt fur Gynakologie 1990; 112: 1389-1398.
7. Vogelzang RL, Nemeck AA, Skrtic Z, Gorrell J, Lurain JR. Uterine arteriovenous malformation: primary treatment with therapeutic embolization. JVIR 1991; 2: 517-522.
8. Matta WHM, Stabile I, Shaw RW, Campbell S. Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fert Steril 1988; 49: 1083-1085.